Defender Capital, LLC.
Source: SEC Form 13F · as of Mar 2026Defender Capital, LLC. holds 2 biotech & pharma companies tracked by BioSniper, totaling $10.8M in value as of Mar 2026 (SEC Form 13F).
Companies held
2
Total value held
$10.8M
BioSniper AIPage context preserved
Prepared research question
What matters most for Lineage Cell Therapeutics, Inc. (LCTX)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| LCTXLineage Cell Therapeutics, Inc. | 6,729,599 | $10.6M |
| GILDGILEAD SCIENCES, INC. | 1,500 | $209K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.